Question 8821
Topic: Biology, Genetics & Bone HealingA 65-year-old woman with metastatic breast cancer is treated with an agent to prevent skeletal-related events. The agent is a monoclonal antibody that targets RANKL. Which of the following is the primary cellular effect of this medication?
Correct Answer & Explanation
. Inhibition of osteoclast formation, function, and survival